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ABSTRACT 
 
Background 
 Type I diabetes mellitus is a chronic metabolic disorder with 
heterogeneous etiologies characterized by hyperglycemia as a cardinal 
biochemical feature.   Patients with Diabetes mellitus are at increased risk 
of morbidity and mortality due to the micro and macrovascular 
complication caused by diabetes.  Maintaining strict glycemic control in 
type I DM reduces the incidence and progression of long term 
complication.  There are various risk factors found to be associated with 
poor glycemic control.  Identification of risk factors associated with poor 
glycemic control is necessary, so that appropriate intervention can be 
done to improve glycemic control and to prevent complication.  As there 
is a lack of regional literature, this study was undertaken in our setting. 
 
Aims and Objectives 
 To study the factors associated of glycemic control in Type I 
Diabetes Children. 
 
Materials and Methods 
 This is a cross sectional study carried out at the diabetes clinic for 
children at tertiary care hospital ICH & HC in Chennai.  Children 
attending the clinic were enrolled into the study after obtaining informed 
consent from the parent / guardian.  A structured questionnaire was used 
to collect date from the parents/guardian.  Glycemic Control was assessed 
by measurement of glycosylated  Hb .Data entry and analysis was done 
using  Epi Info Software Version 3.5.1 and SPSS version 16. 
 
Results 
 99 participants were recruited into the study.  The mean HbA1C 
was 9.16% (SD2.168) came under a fair control group.  31 children had 
age appropriate glycemic control.  The children with good glycemic 
control had a statistically significant level of hypoglycemic p=0.041.  53 
children presented with DKA as initial onset of diabetes mellitus.   
  21 children were hospitalized for inter current illness. 
 
Conclusion 
 The following factors namely age, duration of diabetes, insulin 
regimen, SMBG, compliance to therapy, follow up and serum cholesterol 
did not  have impact on glycemic control.   Hypo glycemic episodes were 
found to be more common in children with good glycemic control which 
was statistically significant. 
 
Keywords 
 HbA1c, Glycemic Control, Type I DM  
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INTRODUCTION 
              Diabetes mellitus is a chronic metabolic disorder with 
heterogeneous etiologies characterized by hyperglycemia and 
disturbances of carbohydrate, fat and protein metabolism resulting from 
defects in insulin secretion, action or both.  
              The incidence of diabetes mellitus is increasing in children. The 
point of concern in children is the acute and chronic complications in the 
long run. Further the need for home monitoring and hospital visits, long 
term involvement of parents and children and the detrimental effect on 
the growth and development of the child are also a great concern. 
 
Classification of Diabetes mellitus 
 
Diabetes mellitus may be classified into 
1. Type I Diabetes – pancreatic beta cell destruction usually leading 
to absolute insulin deficiency. 
A. Immune mediated 
B. Idiopathic 
 
2. Type II Diabetes mellitus – predominantly due to insulin resistance. 
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3. Other specific types 
A. Genetic defects in pancreatic beta cell function – includes various 
form of Maturity onset Diabetes of Young (MODY) 
B. Genetic defects in insulin action 
C. Exocrine pancreatic diseases 
D. Endocrine disorders 
E. Drugs and chemical induced 
F. Infections 
G. Genetic syndromes associated with diabetes 
4. Gestational diabetes mellitus 
5. Neonatal diabetes mellitus 
Type 1 diabetes is an autoimmune disease, in which environmental 
factors are thought to trigger the autoimmune destruction of pancreatic 
b-cells in genetically susceptible individuals. 
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EPIDEMIOLOGY 
The WHO has estimated that about 180 million people in the world 
now have diabetes mellitus and by the year 2030 it is expected to double. 
 Type 1 diabetes is estimated around 10% of all diabetes, affecting 
nearly 1.4 million people in the US and around 10 to 20 million all over 
the world. About 40% of people with type 1 diabetes develop the disease 
before the age of 20 years. 
 Type 1 diabetes mellitus is one of the most common endocrine 
diseases among Children and its incidence is increasing worldwide.  
There is a strong variation in geographical distribution but the 
overall annual increase is estimated around 3%.  Of the 500000 children 
under 15 worldwide, half of them live in the developing nations.  India 
being home to an estimated 97,000 children with type1dm. Recent survey 
has estimated that incidence of Type1 dm in Indian children is around 1 
in 5000.(1) 
Mean annual incidence rates for childhood type 1 diabetes (0–14 
years age group) across the world have varied from fewer than 1 per 100 
000 person years to more than 60 per 100 000 person years in recent 
decades.(2) 
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The incidence of type 1 DM according to Prasanna Kumar et al is as 
follows, the total children population from 0 to 14 years is 1.9 billions.   
 The number of children with type 1 dm is 479.6 thousands. 
 The number of children newly diagnosed is 75.8 thousand per year. 
 The annual incidence of Type 1 dm is 3.0%. (3). 
 
PATHO PHYSIOLOGY OF TYPE 1 DM 
The absolute insulin deficiency in type 1 DM occurs from 
autoimmune destruction of pancreatic β cells in which environmental 
factors play an important role in genetically susceptible individuals. 
IMMUNOLOGY 
 In most cases of type  I DM there is T- Cell mediated autoimmune 
destruction of the pancreatic β cells, in which both the CD4 & CD8 T 
lymphocytes are involved.  The auto antibody seems to appear  many 
years before to the clinical onset of disease, indicating the process of 
destruction is gradual and occurs over a long period.  This provides an 
opportunity to predict and potentially prevent type 1 DM before much β 
cell has been destroyed. 
 
5 
 
The markers of this autoimmune destruction include insulinoma 
antigen 2 antibodies (IA2A), autoantibodies to insulin (IAA), Islet cell 
antibodies (ICA), autoantibodies to glutamic acid decarboxylase 
(GADA).   
A study conducted in Tunishia found a higher prevalence of auto 
immune markers, with 90.7% having 1 or more auto antibodies (4). 
GENETICS 
Familial clustering and twin studies clearly indicate that genetic 
predisposition as a major contribution to Type I DM risk.  Compared to 
the prevalence of 0.4% in general population, prevalence in sibling is 
about 6%.   
The concordance rate ranges from 30-65% in monozygotic twins 
where as dizygotic twins have concordance rate of 6-10%.  The offspring 
of affected father has a chance of 6-7% risk which is more than double 
that of affected mother.   In spite of large genetic component in type 1 
DM 85% of newly diagnosed patients do not have family members with 
type 1 DM.   
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Type  1 DM is mostly associated with HLA class II located in the 
chromosome 6 p21. Most of the classically known predisposition effects 
of HLA DR3 and DR4 are actually due to linkage disequilibrium with 
DQ. 
ENVIRONMENTAL FACTORS 
The environmental factors play an imminent role in the 
contribution to the etiology of type 1 dm .It can be correlated to that, 50% 
or so of monozygotic twins are discordant for type 1 dm, the variation in 
the rural and urban areas populated in same group of people, incidence 
rate changes when people migrate from one region to another and there is 
an occurrence of seasonality. 
Viral infections 
There are various virus seem to play a role in the pathogenesis of 
Type 1 DM but till now no single pathogen and no pathogenesis has been 
proved in the environmental etiology of Type 1DM.  The various viruses 
implicated to the etiology in genetically susceptible host are 
1. Congenital rubella syndrome 
There exists a clearest evidence of role of viral etiology in 
Type1DM  for congenital rubella syndrome. The prenatal infection 
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causes upto 70% of  b cell autoimmunity, out of which  about 40% 
develop the disease of Type1DM.  
2. It has been shown in studies that entero virus has been associated 
with development of diabetes associated antibodies in some 
population (5).   
3. Mumps   
Hygiene hypothesis 
Hygiene hypothesis implies that the lack of exposure to infections 
during the childhood period may somehow increase the chances of 
autoimmune diseases, including Type1DM. Further the rate of auto 
immune disorders and Type 1DM is in a lower range in the 
underdeveloped countries than in the developed nations. 
Diet 
The risk of Type1DM decreases with breast feeding due to either 
directly or indirectly by the delay in the cows milk exposure. If there is an 
early introduction of cows milk or to gluten the chances of developing 
autoimmunity is high due to the leakiness of the immature gut to the 
protein antigens. 
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Other dietary factors implicated are 
- Omega 3 fatty acids 
- Vitamin D, Vitamin C, Vitamin E  
 - Zinc 
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COURSE OF DISEASE PROCESS 
The natural course of Type IDM involves the following stages. 
1. Initiation of auto immunity. 
2. Preclinical auto immunity progressive loss of β –cell function. 
3. Onset of clinical disease. 
4. Transient remission. 
5. Established disease. 
6. Development of Complication. 
Initiation of autoimmunity 
There are multiple factors implicated in the initiation of 
autoimmune process namely genetic susceptibility, environmental factors 
like diet during infancy, viral infection and even psychological stress.  In 
the majority of the children who are diagnosed before 10 years of age, the 
first signs of autoimmunity appear before 2 years of age. 
Onset of Clinical disease 
The onset of clinical disease of  Type 1DM indicates that there is a 
progressive  β –cell destruction.  It appears that, in younger children the           
β –cell destruction is more rapid and complete than the older children and 
adults.  Studies indicate that 40% of the β –cell mass is preserved, this 
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may be important in a newly diagnosed patients where secondary 
prevention is possible. 
 During the onset of clinical disease the following symptoms occur  
 Increased thirst 
 Increased Urination 
 Weight loss despite increased appetite. 
Honey Moon Period 
 In this phase, when the patient in initiated on insulin therapy, the          
β –cells regain the functional capacity, producing some insulin for a short 
period of time. 
Intensification Phase 
 During this phase the destruction of β –cells continue and control 
of blood glucose is much  more difficult. 
Total diabetes :  This phase is characterized  by complete insufficiency 
of insulin due to total destruction of β –cells. 
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Clinical Features and Complication of Type IDM 
 The patient present with different clinical features  depending on 
the degree of insulinopenia.  The  symptoms arise due to hypoglycemia, 
glycosuria and ketoacidosos. The classical symptoms of diabetes are 
polyuria, polydypsia and weight loss. Non specific features like malaise, 
headache and weakness. 
 When there is extremely low level of insulin keto acidosis 
develops, which may also be an initial presentation in children.  DKA 
manifests as dehydration, vomiting, abdominal pain, breathing becomes 
acidotic and sensorium decreases, finally coma occurs. 
Micro and Macrovascular Complications 
The most important primary pathogenic factor for the development 
of complications in Type 1 diabetes mellitus is hyperglycemia.  
Hyperglycemia leads to activation of various biochemical reaction.  The 
pathogenic pathways involved are 
a) Accumulation of polyol 
b) Formation of advanced glycation end products         
c) Injuries caused by oxidative stress 
d) Finally there is activation of protein kinase C 
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  The above mechanisms make a combined effect and then leads to 
further cellular, structural and functional changes. 
The biochemical alteration leads to both Acute and Chronic 
complication.  The Acute Complications that manifests in Type1DM are 
DKA and hypoglycemia while chronic complication include retinopathy, 
nephropathy, neuropathy and growth disturbances. 
HYPOGLYCEMIA 
The most common acute complication of Type 1 DM in children is 
hypoglycemia.  The symptoms of mild hypoglycemia are mostly due to 
the compensatory sympathetic stimulation like tremor, pallor, cold sweat 
and palpitation. As the glucose level further decreases symptoms of neuro 
glucopenia predominates like fatigue, lightheadedness, confusion, loss of 
consciousness.  If there is a frequent bouts of hypoglycemia it can result 
in hypoglycemic unawareness  
 In hypoglycemic unawareness there is progressive decrease in 
blood glucose levels to elicit catecholamine  counter regulatory response, 
so these patients are at increased risk of hypoglycemia associated 
autonomic failure. 
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The hypoglycemia can be prevented if the mismatch between three 
major components namely Insulin, exercise and food  intake are managed 
properly. 
When prolonged exercise is anticipated carbohydrate in take is 
recommended. 
Newer insulin regimens by using long acting analogs are less likely 
to induce overnight hypoglycemia. 
and glargine substitution for NPH has advantages. 
DIABETIC KETOACIDOSIS 
 The most severe and life threatening acute complication of 
Diabetes is DKA.  It is estimated that DKA occurs in 20-40% of children 
with new onset diabetes and children with known diabetes who omit 
insulin doses .If inter current illness is not managed adequately DKA 
occurs.   
The incidence of DKA is around 46 cases per 10,000 persons by 
Faich et al.(6). 
DKA involves a condition of low insulin levels and elevated 
counter regulatory hormones especially glucagon. 
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1. As the diagnosis of diabetes in younger children is more difficult 
and it is more likely to be delayed, infants and younger children 
age less than 5 years are in greatest risk of presenting with DKA. 
The clinical presentation of moderate to severe DKA are 
nausea, vomiting and abdomen cramps.   Coma and disorientation 
are ominous signs and emergency assessments must be made for 
cerebral edema. 
The classification of DKA is Mild, moderate and severe. 
Diagnosis of T1DM: 
 
Current guidelines by the American Diabetes Association (ADA) 
recommend making  a diagnosis of DM based on any of the following 
criteria(1): 
 
1. HbA1c  6.5% 
2. Fasting plasma glucose 126 mg/dl (7.0 mmol/l). Fasting is defined 
as no caloric intake for at least 8 hours. 
3. 2-hour plasma glucose 200 mg/dl (11.1 mmol/l) during an OGTT. 
4. In a patient with classic symptoms of hyperglycemia or 
hyperglycemic crisis, a random plasma glucose 200 mg/dl (11.1 
mmol/l).  
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The current World Health Organization (WHO) guidelines 
published in 2006 in Consultation with the International Diabetes 
Federation (IDF) recommend using fasting plasma glucose of 7 mmol/l or 
a 2 hour plasma glucose of  11.1 mmol/l during an OGTT as diagnostic 
criteria. 
 
 
Management of Type1DM 
The management of Type I DM involves many complexities it 
needs a team of person helping the patients to achieve and maintain the 
glycemic targets.  Depending on the circumstances and available 
resources the multidisciplinary team should include the patient, diabetes 
specialist, primary care physician, dietician, nurse, psychiatrist as well as 
family and friends. 
The Primary goals of therapy include: 
 Establishment of realistic glycemic targets and insulin regimen 
adopted to each individual. 
 The blood glucose in maintained to a near normal range as well as 
HbA1c to an optimum level. 
  Efforts to reduce mortality and morbidity by preventing severe  
hypoglycemia and  DKA  should be made. 
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 The affected children quality of life should be maintained to a 
reasonable level.  
 Proper screening for the expected  micro and macrovascular 
complications 
 Growth and development including psychological maturation 
should be attained to a optimum level. 
 
Insulin therapy 
Insulin therapy in the mainstay of treatment in children with Type I 
Diabetes. The ideal management is to hospitalize the child for 4 to 5 days 
even in the absence of any complication, to help the family to tide over 
crisis and also to gain support and confidence of home monitoring and 
treatment. 
Insulin Preparation 
Insulin analogues 
The biochemical alteration of the insulin molecule alter its onset, 
peak and duration of action, so that it mimics the insulin action produced 
by the β –cells of the pancreas. 
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Short acting insulin analogues 
Lispo and Aspart are the two short acting analogues.  They have a 
rapid onset of action within 15 minutes, and the duration of action ranges 
from 2 to 4 hrs and 4 to 6 hrs respectively.  It rapid onset of action makes 
it ideal for administration just before eating. 
Intermediate acting insulin 
Neutral protamine Lispro insulin (NPL).  These are premixed 
insulin preparation similar to the human insulin NPH.   
Advantages are  
          - Easy to administered in two daily doses. 
- Used for patients who are not able to be successful in the 
task of mixing insulin. 
Disadvantage 
- Do not allow independent adjustments of either rapid or 
intermediate acting insulin. 
Long acting Insulin 
Insulin Glargine 
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It is a clear U 100 insulin preparation, as it is acidic it cannot be 
mixed with other insulin preparation.  It has a peakless action and a 24 
hour duration of action. 
It should be given  as 25-30 % of the total dose in toddlers and 40-
50% in older children. 
Advantages 
Peakless action. 
Less nocturnal hypoglycemia 
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Insulin Dose 
The newly diagnosed type I DM children require approximately 0.5 
to 0.75 U/kg/day. 
There are some conditions where insulin sensitivity is decreased 
and they need a higher dose of insulin about  1U kg/ day or more.The 
conditions are 
 DKA,  
Steroid use,  
puberty  
and  infection. 
The newly diagnosed children within a period of initiation of 
insulin therapy they may enter into honey moon phase where there is 
residual insulin production.  The insulin requirement usually falls below 
0.5 U/kg/day.  As the destruction of β- cell progresses, the insulin dose 
gradually increases may require 1.5U/kg/day during puberty. 
Insulin regimens 
Conventional Insulin therapy:- 
It refers to 1-2 times per day of insulin injection.  The total daily 
dose is divided into 2/3 pre breakfast and 1/3 pre dinner.  The ratio of 
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intermediate action and short acting (human regular) (NPH/Lenti) is 
taken in 70:30 ratio.  Insulin is started at 60-70% of the total replacement 
dose.  This has got less risk of hypoglycemia and more chances of 
microvascular complication. 
Intensive regimen 
This consists of completely separate basal and bolus administration 
where  in a single day more than 3 times  insulin is given.  It has a basal 
insulin and bolus insulin given before food intake.  This can be 
administered by multiple subcutaneous injection or continuous 
subcutaneous insulin infusion. 
In this regimen the risk of hypoglycemia is more so that BGM is 
required 4-5 times/ day.  But has a lower risk for microvascular 
complication. 
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Table 1: Insulins available in India and their action profile 
Insulins Onset Peak Duration 
Rapid-acting 5-15 min 30-90 min 4 hrs 
 Lispro     
 Aspart    
Short-acting 30-60 min 2-3 hrs 6-8 hrs 
 Regular    
Intermediate-acting 1-2 hrs 4-6 hrs 10-16 hrs 
 NPH    
Long-acting 2-4 hrs No peak 20-24 hrs 
 Glargine Detemir    
Pre-mixed 
30% / 70% regular/NPH 
50% / 50% regular/NPH 
30-60 min Dual 10-16 hrs 
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GLYCEMIC CONTROL 
Strict glycemic control is needed to reduce the long term 
complications of Type 1 dm. This was proven in DCCT(Diabetes Control 
and Complication Trial)the multi centred trial done in1441 patients 
showed a strong association between long term  glycemic control and the 
risk of microvascular complications .It has showed that intense diabetic 
treatment delayed the onset and progression of dibetes related 
complications.(7) 
The main objective parameter assessed for glycemic control is the 
glycosilated hemoglobin (HbA1c) along with monitoring blood glucose 
levels. 
The age group wise goals recommended by the American Diabetic 
Association in the year 2001 for plasma blood glucose and HbA1c for the 
Type 1 Diabetes is as follows :  
 
1. The toddlers and preschoolers 0 to 6 years is  
Plasma blood glucose 
a) Before meals 100 to 180 mg /dl 
b) During Bedtime /overnight is between 110 to 200mg/dl 
     HbA1c is less than 8.5% 
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2. For the school age children is 
Plasma blood glucose 
a) Before meals 90 to 180 mg /dl 
b) During Bedtime /overnight is between 100 to 180mg/dl 
    HbA1c is less than 8% 
3. For the adolescents and young adults is  
Plasma blood glucose 
a) Before meals  90 to 130 mg /dl 
b) During Bedtime /overnight is between 90 to 150mg/dl 
    HbA1c is more than 7.5% 
The following features should be taken into account while setting 
the glycemic controls 
a) It should be individualized and the lower goals should be reasoned 
out on risk benefit assessment. 
b) If the children has frequent hypoglycemia and hypoglycemic 
unawareness the goals should be modified accordingly. 
c) When there is a discrepancy between pre prandial blood glucose 
values HbA1c values the post prandial blood sugar value should be 
measured so that it helps in assessing the glycemia in patients on 
basal bolus regimen.  
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ASSESSMENT OF GLYCEMIC CONTROL 
GLYCEMIC CONTROL 
Theortical goal of treatment is to restore the metabolic function to a 
possible near normal range and avoiding serious complications of 
therapy, especially symptomatic hyperglycemia and hypoglycemia.  
Although, most target recommendation for glycemic control are based on 
the data obtained from studies of adult patients with diabetes.  The ideal 
goal for near normalization of blood glucose levels in children and 
adolescents is generally the same as that for adults (8).  
  Several studies indicate that hypoglycemic unawareness causes 
cognitive impairment in children who develop diabetes during infancy 
and early childhood (9)(10).  Therefore maintaining very tight control of 
glucose level in children may be harmful.   Further the long term follow 
of the DCCT participants were re assuring that there was no evidence of 
permanent neuro cognitive changes related to hypoglycemia in 
adolescents and young adults suggesting it may be age depend (11).  
 Care must also be taken to avoid poor glycemic control.  Study 
conducted by schoenle EJ et al found a correlation between high long 
term HbA1c values and intellectual impairment in boys diagnose below 6 
years of age (12).  The prepubertal childrens are relatively protected from 
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microvascular complication, indeed it is extremely rare in children 
younger than10 years of age (13). 
PUBERTY 
Puberty is a challenging period of diabetes management from both 
physiological and behavioural point of view.  Due to increase in the 
production of growth hormone and sex steroid hormones there is 
significant increase in insulin resistance and insulin requirements increase 
by 50% during pubertal growth and development (14).   
Together with the physiological demands of puberty, behavioural 
issues add to the challenge of diabetes during developmental stage (15).      
SMBG 
Self monitoring of blood glucose enables the patients to evaluate 
their response to therapy and assess whether glycemic targets are being 
achieved or not .  SMBG value can be useful in monitoring hypoglcemia 
and hyperglycemia so that medication can be adjusted.  SMBG values are 
confounded by Aspirin, mannitol, paracetamol, vitamin C, vitamin E and 
hematocrit. 
There is a significant bias in 41% of instruments which result in 
potential mis classification of > 12% of patients.  SMBG recommended           
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3 – 4 times per day for diabetic patients on intensive treatment (16).  
Decreased frequency of blood glucose monitoring has been found to be a 
predicator of poor glycemic control (17),(18).  Study by syein et al and 
Gunn B.B.  Kristensen et al has observed that focused self monitoring of 
blood glucose intervention can lower HbA1c.  A study in denmark 
showed imporved glycemic control with more frequent SMBG (19). 
HbA1c 
HbA1c is the most important parameter commonly measured for 
assessing chronic glycemia in current clinical practice.  HbA1c is 
considered as a therapeutic target in the prevention and delay in the 
development of hyperglycemic complication. 
ADA  published the target age specific HbA1c is as follows. 
<6yr  7.5 - 8.5% 
6-12yr < 8% 
13-18yr <7.5% 
The glycation of hemoglobin takes place non-enzymatically in a 2 
stage process within the erythrocytes.  Initially there is a transient rise in 
glucose leading to a reversible formation of an aldimine.  After prolonged 
exposure an Amadori rearrangement takes place forming an irreversible 
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ketoamine.  The HbA1c value gives a time weighted indication of the 
average blood glucose over the life span of RBC.   
It can be measured by the following method. 
a) Cation exchange chromatography (HbA1c) 
b) Affinity binding chromatography 
c) Immunoassay 
Cation exchange chromatography  
It is a method in which separation is achieved by utilizing the 
differences in ionic interaction between the cation exchange group on the 
column resin surface and components of hemoglobin in the sample. 
Advantages of  (HbA1c) 
 It has substantially less biological variability and less                      
pre analytic instability. 
 Does not need for fasting and timed samples. 
 It is relatively un affected by perturbation in glucose levels. 
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REVIEW OF LITERATURE 
Effect of Age and duration on Glycemic control 
 Studies conducted in FRANCE and UK have shown that older 
age and longer duration of DM were associated with poor 
control.(18) (20). 
 Panamonta et al conducted retrospective cohort study included 
43 patients has found that higher age and longer duration of 
T1DM  is associated with high risk of complications( 21). 
 A study conducted in  Sudan showed an inverse relationship 
with older duration and higher duration is associated with good 
control (22) .Probable explanation is that these patients have 
better knowledge of diabetes and its management. 
The Effect of sex as a factor on glycemic control 
Dovk et al conducted a prospective study in 886 pediatric patients  
between the year  2000  to 2011 and has observed that  the female 
patients had HbA1c value of an average 1.02% higher level(p=0.01)(23.). 
Fritch et al in his study on predictors of DKA in children and 
adolescents with type 1 diabetes observed that adolescents girls with 
diabetes developed ketoacidosis than adolescents boys( 24) 
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 The effect of BMI on glycemic control 
 
Viner RMet al  conducted a longitudinal study in british people 
and have Observed that higher BMI in childhood independently increased 
the risk of Type 1 diabetes, this also supports the suggestions that obesity 
may provide link between type 1 and type 2 diabetes(25) 
 
 
Ferrieria-Hermosilo et al performed a transverse evaluation in 
120 patients with type 1 DM and has observed that BMI  had a statistical 
significant  p value when correlating with  glycemic control(26) 
 
The effect  of Diabetes knowledge of caregivers on glycemic control 
 In the Michiagen diabetes research and training centre, diabetes 
knowledge test done by  Stallwood etal  observed that higher 
caregiver knowledge  was associated lower glycemic level( 27). 
 Similarly Butler et al observed that higher parental diabetic 
knowledge and less parental burden towards the care of diabetic 
children were predictive of lower HbA1C value.(28). 
 However in India  it was observed that, planned educational 
intervention program on the knowledge attitude and practices of 
type 1 diabetes resulted in significant improvement in the 
knowledge and attitude but no change in practice hence no 
improvement in HbA1C levels 
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The effect  of adherence to insulin regimen on glycemic control 
 Study conducted by Elgerbi in Zawia university among one 
hundred children with type 1dm have observed that poor 
compliance with insulin therapy was associated with poor 
glycemic control(29) 
 The effect of  dosage of insulin on  glycemic control 
Studies from Newzealand, France and Australia have found that 
higher insulin dose per kg b.wt, poorer the glycemic control (17),(18).  
 Cameroglu et al and Thomas et al  in his study on basal and bolus 
insulin requirements in children ,participants included  154 patients aged 
between 3 and 12 years and have found that basal  insulin requirement 
increased with puberty in both the sexes and was lowest in the youngest 
group(30). 
The effect of insulin regimen on  glycemic control 
Raskin et al  conducted study in comparing insulin glargine verses 
NPH insulin have consistently shown that there is significant lower 
plasma glucose and a significant decrease in the variability of fasting 
blood glucose values in glargine pooled groups (31).   
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Rosenstock et al conducted a randomized controlled trial of 
comparing insulin glargine plus lispro with NPH plus regular insulin on 
intensive insulin therapy showed no significant differences in HbA1c 
levels and rates of self reported symptomatic hypoglycemia (32). 
 The effect of follow up visits  on  glycemic control 
Hood et al conducted a meta analysis with a study population of 
about 2492 youths with type 1 dm observed that as the adherence 
increases ,HbA1c value decreases .It had a mean effect size of 0.28 (95% 
confidence interval:0.32 to 0.24 (33). 
Adherence to any treatment regimen is particularly difficult if 
patients did not come to clinic in regular manner. 
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COMPLICATIONS RELATED 
HYPOGLYCEMIC EPISODES 
Johansen et al conducted a study in 3320 Danish children and 
adolescents in which hospital data were analyzed  and observed that 
overall incidence of severe hypoglycemia was 45.1(95% confidence 
interval) per 100 patient years. He also added that patients treated with 
five or more insulin injections had a 31% reduced risk of hypoglycemia 
compared to patients on fewer daily injections.(34) 
DKA 
Jesic et al conducted a study among 366 children with  type 1 
diabetes mellitus, who are aged less than 18 years .It was conducted in 
Serbia and he observed that of all the children diagnosed as type 1 dm  
32.9% presented with DKA. In that majority had either mild 69.6% or 
moderate 22.8% DKA  presentation (35). 
Johnson et al has observed that apart from the short term mortality 
there appears an increased risk of microvascular complications of 
diabetes with long-term survivors of DKA.  (36)  
From the studies conducted by Barnes et al it has been observed that the 
severity of DKA is less in patients where there is deficiency of counter 
regulatory hormones.  (37). 
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COMORBID CONDITIONS 
1) THYROID 
Jung et at conducted a study on  autoimmunity in 73  children with 
type 1 diabetes and found that majority of patients 87.7% had atleast one 
antibody .The   significant higher antibody was  insulin autoantibodies 
IAA. He also concluded that positivity of thyroid antibody could be used 
as an early predictor of development of thyroid autoimmune disorder 
among children and adolescent with type 1 DM.(38).  
2) HYPERLIPIDEMIA 
A cross sectional study conducted by Guy J et al, compared lipid 
profile and the prevalence of lipid abnormalities in 512 youths with type 
1DM with mean duration 4.22 years, and has observed that youth with 
sub optimal level  of glycemic control had elevated standard lipid levels 
of total cholesterol, LDL cholesterol .They also had significant elevated 
levels of apolipoprotein B and more small dense LDL particles. He 
concluded that youth with type 1 DM have abnormal lipid levels and 
atherogenic changes in lipoprotein composition even after small duration 
of diabetes.(39) 
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STUDY JUSTIFICATION 
Type I DM is a growing problem in southeast  asian countries. The 
WHO has recognized that developing countries face a double disease 
burden of both communicable and non communicable diseases. The non 
communicable disease has a major contribution to morbidity and 
mortality.  Studies from different parts of the world have found a number 
of risk factors that predict poor glycemic control.  Whether similar kind 
of variables play a role is to be determined in our resource poor settings.  
As the Regional literature of glycemic control in Type I DM is scarse, 
hence called for this study in our setting 
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AIM OF THE STUDY 
AIM OF THE STUDY 
To study the factors associated with glycemic control in children 
with Type 1 diabetes mellitus attending the diabetic clinic. 
  
OBJECTIVES 
 To determine the effect of social and demographic factors, 
diabetes related factors and comorbid conditions on glycemic control.  
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METHODOLOGY 
STUDY METHOD 
Cross sectional study 
STUDY PLACE 
ICH&HC, MADRAS MEDICAL COLLEGE 
STUDY PERIOD 
MARCH 2014 TO SEPTEMBER 2014 
STUDY POPULATION  
99 Children attending the diabetic clinic at ICH&HC 
STUDY METHOD 
This study was carried out in the tertiary care children hospital 
ICH& HC in Chennai. In this hospital the study was done in diabetic 
clinic which is conducted two times in a week on Tuesday and Friday.   
Data was collected by the principal investigator using the structured 
questionnaire from the participants and parents/guardians 
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INCLUSION CRITERIA 
Children with Type 1 diabetes mellitus attending to our clinic   
with age from  1 to 12 years. 
  The duration diabetes of more than 6 months 
EXCLUSION CRITERIA  
Newly diagnosed type 1 diabetes mellitus 
METHOD OF COLLECTION OF DATA 
Data was collected by Principal  investigator using a structured 
questionnaire 
The questionnaire has the following parameters  
1. SOCIODEMOGRAPHIC FACTORS 
Age, Sex, BMI 
Primary care giver 
Education of the primary care giver 
Family history and family structure 
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2. DIABETES SPECIFIC RISK FACTORS  
Onset and duration of diabetes 
Insulin related factors 
-Insulin dose 
- Insulin regimen and mode of administration 
Adherence to insulin  
  Follow up 
SMBG 
3. OTHER PARAMETERS COLLECTED 
a) COMPLICATIONS RELATED 
     Hypoglycemic episodes 
     Hospitalization for inter current illness 
    Episodes of DKA 
b) INVESTIGATORY PARAMETERS 
1)HbA1c 
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In addition to routine and specific investigations, HbA1c 
estimation of all cases was done with high-performance liquid 
chromatography (HPLC) and the children were assessed for glycemic 
control as per American Diabetes Association Criteria by classifying 
them into preschoolers, school age and adolescents with HbA1c of          
< 8.5%, < 7.5% and < 7% respectively 
2)Lipid profile 
3)Thyroid profile 
 
DIABETES RELATED 
INSULIN REGIMEN 
The patients in the study were following two types of insulin 
regimen one is twice daily regimen in which the soluble and long acting 
insulin are given in two doses per day. The other one is the multiple 
insulin dose regimen where basal or long acting insulin is given once or 
twice daily and bolus doses of short acting insulin were given in between. 
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INSULIN ADHERENCE 
It is the degree to which patients adhere to their insulin regimen.  
This parameter was assessed by the number of insulin doses missed 
in the last one week 
Good - no missed doses / less than 3 missed doses per week 
Poor - 3 or more than 3 missed doses per week 
SMBG adherence 
It is the degree to which the patients adhere to their SMBG testing at 
home  
This was assessed by  
Good - two times per week 
Poor - less than 2 times per week 
FOLLOW UP 
 In our diabetic clinic the assessment of follow up is done by the 
number of visits the children makes in 1 year period  
Regular - 10 or more than 10 visits per year  
Irregular - less than 10 visits per year 
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HYPOGLYCEMIC EPISODES 
1) yes 
This parameter is assessed by further classified into 
a) symptomatic  
mild- tremor, pallor, cold sweat and palpitation 
moderate to severe –fatigue, lightheadedness, confusion, 
loss of consciousness and convulsion.  
b) asymptomatic – blood glucose < 60 mg/dl 
                                                 <3.3mmol/L      
2) no  
HOSPITALIZATION 
During the study period if the child has been admitted for any inter 
current illness this has been taken into account. 
EPISODES OF DKA 
This is another acute severe complication of type1 dm 
It is taken into account by whether the child had DKA during study 
period of 6 months. 
COMORBID CONDITIONS 
Lipid profile  
Thyroid profile 
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ANTHROPOMETRY   
Weight 
An electronic weighing machine is used to measure the weight. 
During weighing the children were allowed for little clothing due to 
cultural restrains. It was checked thoroughly that the child did not make 
any contact with the objects nearby. It was measured upto the nearest 
100gms. 
Height 
For children less than 2 years the length is measured using an 
measuring rod or infantometer. To measure length two persons are 
needed. Shoes must be removed and child was placed on a flat surface. 
The accompanied person usually the mother holds the head on the 
vertical board with child eyes facing upwards.  The other person usually 
the trained person firmly presses the knees down so that they touch the 
horizontal surface. Then the mobile footboard was moved to touch the 
heels keeping the foot at right angle. Nearest 0.5cm was used to adjust the 
accuracy. If the child is more than two years old, stadiometer or vertical 
measuring rod was used. After removing the shoes the child was made to 
stand bare foot and the heels, buttocks, shoulders and occiput were 
touching the wall and child was looking straight. The chin was also 
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straight during the measurement (in Frankfurt planes).The curser or 
wooden board was placed  flat on the head so that hair is flattened. Here 
the accuracy is measured to nearest 0.5cm.      
In this clinical examination, the participants weight and height are 
measured accurately so that the insulin dosage body mass index can be 
calculated 
BMI 
The BMI is calculated and plotted using the WHO BMI for age  Z 
score  chart The results of Z score is interpreted in the following manner 
1. Above 3  - Obese 
2. Between 2 to 3 - Overweight 
3. From 1 to 2  - Possible risk of overweight 
4. From 1 to -2  - Normal 
5. From   -2 to -3 - Wasted 
6. Below -3  - Severely wasted 
Research assistants  
In the diabetic clinic a nurse and a member of the support staff 
were selected to assist in the research for this study. They both were 
trained on how to use the weight and height scales accurately to measure. 
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STATISTICAL ANALYSIS 
 
The collected data was first entered and cleaned then finally 
analyzed using Epi Info Software version 3.5.1 and SSPS (Software 
package for statistical sciences) version 16. The data regarding 
demographic characters and diabetic specific variables were plotted using 
frequency distribution tables. The mean was calculated for continuous 
data. 
To derive the outcome of the association between the variables it 
was tested using chi square and fishers exact test. The derived statistical 
analysis of the mean was done using the t test and the ANOVA test. The 
derived value is considered statistically significant when the p value is 
less than or equal to 0.05. 
ETHICAL CONSIDERATION AND CLEARENCE 
The ethical clearance was obtained from the institutional review 
board. 
The participants in the study were enrolled after obtaining written 
informed consent from the parents or from the guardian.  
The confidentiality of the data collected during the study was 
maintained.     
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RESULTS 
A total of 99 children with Type 1 diabetes mellitus were 
included and analyzed during the study period. 
Age Group Frequency Percent 
<6yrs 10 10.1 
6-10 yrs 34 34.3 
10-12yrs 55 55.6 
Total 99 100.0 
 
Table 1 shows that among the 99 students studied 
1. 55.6% of the children belong to the maximum group of age from 
10 to 12 years 
2. Next comes the 6 to 10 years of age children  to 34.3%  
     3  Children of less than 6 years occupy a small percentage of 10% 
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The chart 1 shows that majority of children in this study constitute 
to 10 to 12 years  of age  
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SEX DISTRIBUTION 
Sex Frequency Percent 
Male 47 47.5 
Female 52 52.5 
Total 99 100.0 
 
Table 2 shows that among the 99 students studied 
1. Female  children  constitute 52.5% while the male have 47.5%  
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Chart 2.that the sex distribution chart shows a minor difference in 
distribution among childrens of type 1 dm 
Females have a distribution of 52.5% 
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BMI GROUP 
BMI Frequency Percent 
Over wt 2 2.0 
Risk of Over Wt 6 6.1 
Normal 80 80.8 
Wasted 6 6.1 
Severly wasted 5 5.1 
Total 99 100.0 
 
Table 3 shows that among the 99 children studied belong to 
1. Majority of the children  about 80% belong to a normal range of 
BMI  
2. About 6 and 2 percentage of children occupy the higher BMI range 
of risk of overweight and over weight respectively. 
3. The wasted and severely wasted children  occupy Nearly 6% each. 
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Chart 3 shows that 80.8% of children in the study group have normal 
BMI for age 
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CARE GIVER 
Caregiver Frequency Percent 
Father 11 11.1 
Mother 84 84.8 
Sibling 2 2.0 
Guardian 2 2.0 
Total 99 100.0 
 
Table 4 shows that among the 99 children studied 
1. In 84.8% of children mother were the primary care giver 
2. The care giver percentage of father was 11 whereas sibling and 
guardian had 2% each.  
  
52 
 
EDUCATION OF PARENTS/CARETAKER 
Education Frequency Percent 
Illiterate 11 11.1 
Primary 7 7.1 
secondary 19 19.2 
High school 33 33.3 
UG/PG 17 17.2 
Professional 12 12.1 
Total 99 100.0 
 
Table 5 shows that among the 99 children studied  
1. 33.3% of care givers has studied upto high school 
2. 19% completed secondary, 
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FAMILY STRUCTURE 
Family structure Frequency Percent 
Both 94 94.9 
Single 2 2.0 
No parent 3 3.0 
Total 99 100.0 
 
Table 6 shows that among the 99 children studied 
 94% live with both the parents 
 2 to 3% live with a single or without parents 
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Yes
Frequency
Percent
FAMILY HISTORY OF TYPE 1 DM 
Family history of     
type 1 dm Frequency Percent 
Yes 6 5.9% 
No 93 94.1% 
Total 99 100.0 
 
Table 7 shows that among the 99 children studied 5.9%  have a 
family history of  type 1DM  
 
 
 
 
 
 
 
The pie chart shows the percentage of family history of type1 
diabetes in our study  
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MODE OF ONSET OF TYPE1 DM  
Mode of onset Frequency Percent 
DKA 53 53.5 
Non DKA 46 46.5 
Total 99 100.0 
 
Table 8 shows that among the 99 children studied 
The mode of onset of DM with DKA was 53.5% whereas non - 
DKA was 46.5% 
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The chart 5 shows minimal higher level of onset for DKA children 
of 53.5% 
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DURATION OF DIABETES 
Duration of 
Diabetes Frequency Percent 
< 1 year 4 4.0 
1-3 yrs 46 46.5 
3-5 yrs 18 18.2 
>5 yrs 31 31.3 
Total 99 100.0 
 
Table 9 shows that among the 99 children studied 
1. 46.5% belong to 1 to 3 years duration 
2. 31% had more than 5 years of duration 
3. 18% and 4% had 3 to 5 years and  less than 1 year duration of   
    disease respectively  
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The chart 6 shows maximum duration of disease in 1 to 3 years        
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INSULIN DOSAGE 
Insulin dosage   
U/kg b.wt Frequency Percent 
0.5-0.99 22 22.2 
1.0-1.49 51 51.5 
1.5-2.0 23 23.2 
>2.0 3 3.0 
Total 99 100.0 
 
Table 10 shows the insulin dosage  among the 99 children studied 51.5% 
had 1.0.to 1.49U/kg bwt, 23.2% had 1.5 to 2.0U/kg bwt 22.2% had 0.5 to 
0.99 U/kg.bwt.3% had >2 U/kg bwt 
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Chart 7 The bar diagram shows that majority of children are in a insulin 
dose of  1 to 1.5U/kg b wt  
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REGIMEN OF INSULIN 
Regimen Frequency Percent 
Twice 77 77.8 
Thrice 22 22.2 
Total 99 100.0 
 
Table 11 shows that among the 99 children studied 
1. Children on two dose regimen  is about 77.8% 
2. 22% children are under three dose regimen 
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MODE OF INSULIN ADMINISTRATION 
Mode Frequency Percent 
Pen 11 11.1 
Conventional 88 88.9 
Total 99 100.0 
 
Table 12 shows that among the 99 children studied 
1. Children injecting in conventional method is 88.9%, while 11.1% 
use pen  
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SMBG 
SMBG Frequency Percent 
Twice a week 84 84.8 
Less than Twice a week 15 15.2 
Total 99 100.0 
 
Table 13 shows that among the 99 children studied 
Twice a week 84.8%, less than twice a week 15.2% 
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COMPLIANCE 
Compliance Frequency Percent 
Good 76 76.8 
Poor 23 23.2 
Total 99 100.0 
 
Table 14 shows that among the 99 children studied  
 Good compliance 76.8% 
 Poor compliance 23.2% 
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The chart 8shows the majority of the children about 76.8% have 
good compliance to insulin therapy compared to 23.2% have poor 
compliance. 
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FOLLOW UP GROUP 
 
Follow up Frequency Percent 
Regular(>=10 visits) 44 44.4 
Irregular(<10 visits) 55 55.6 
Total 99 100.0 
 
Table 15 shows follow up visits of the children in the study group 
1. There is a minimal difference of 10% between the above 
mentioned group. 
2. The children who come irregularly to the clinic constitute about 
55.6% compared to 44% of patients who come regularly. 
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The chart 9 shows that 55.6% have an irregular visit to the diabetic clinic 
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HYPOGLYCEMIC EPISODES 
Hypoglycemic Episodes Frequency Percent 
Symptomatic 43 43.4 
Asymptomatic 14 14.2 
No 42 42.4 
Total 99 100.0 
 
Table  16  shows frequency of  hypoglycemic episodes of  children in the 
study group 
Episodes of hypoglycemia seen in 57.6%, out of that 43.4% was 
symptomatic, 14.2% were asymptomatic. 
There was no hypoglycemic episodes in 42.4% of patients. 
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HOSPITALIZATION 
Hospitalization Frequency Percent 
Yes 21 21.2 
No 78 78.8 
Total 99 100.0 
 
Table 17 shows that among the 99 children studied 
21% of children had hospitalization for inter current illness 78% of 
children did not need hospitalization. 
 
 
 
 
 
 
 
70 
 
 
DKA 
DKA Frequency Percent 
Yes 5 5.1 
No 94 94.9 
Total 99 100.0 
 
Table 18 shows that among the 99 children studied 
About 94.9% of children did not have complication of DKA Only 
5% had episodes of DKA.  
71 
 
SERUM CHOLESTEROL 
Cholesterol Frequency Percent 
Normal 47 47.5 
Abnormal 21 21.2 
Total 68 68.7 
Missing  31 31.3 
Total 99 100.0 
 
Table 19 shows the serum cholesterol among the 99 children studied 
Normal in 69.1%, Abnormal in 30.9%. 
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SERUM TRIGLYCERIDES 
Triglycerides Frequency Percent 
Normal 39 39.4 
Abnormal 24 24.2 
Total 63 63.6 
Missing  36 36.4 
Total 99 100.0 
 
Table 20 shows the serum triglycerides among the 99 children studied 
Normal in 61.9% ,Abnormal in38.1%. 
 
The missing data are due to the children who did not come to 
diabetic clinic in fasting state to do lipid profile.  
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AGE GROUP WITH MEAN HbA1C 
Age group N Mean HbA1c Std. Deviation 
<6 yrs 10 8.440 1.4393 
6-10 yrs 34 8.812 2.3314 
10-12 yrs 55 9.505 2.1377 
Total 99 9.160 2.1681 
 
Table 21shows Age group with mean HbA1c 
 
In this study the mean glycosylated hemoglobin was 9.16%.      
(SD 2.1681) 
The lower age group had a low HbA1c value of 8.4% 
The higher age group children had high HbA1c value of 9.5%    
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Statistical test was done to analyze the association between glycemic 
control (HbA1c) and the following parameters   
1. Age of the children 
2. Duration of diabetes 
3. Insulin dose 
4. Insulin regimen 
5. SMBG 
6. Compliance to therapy 
7. Follow up 
8. Hypoglycemic episodes 
9. Serum cholesterol 
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AGE WITH  HbA1c 
Age  
HbA1c gp 
Total 
Control Un control 
<6yrs Count 3 7 10 
% within age gp 30.0% 70.0% 100.0% 
6-10 yrs Count 14 20 34 
% within age gp 41.2% 58.8% 100.0% 
10-12yrs Count 14 41 55 
% within age gp 25.5% 74.5% 100.0% 
 Count 31 68 99 
 % within age gp 31.3% 68.7% 100.0% 
 
P = 0.738 
Table 22 shows no significant association between age and glycemic 
control 
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The above chart 10 shows that the children belonging to the age 
between 10 to 12 years are the majority section of poorly controlled 
group. 
Second comes less than  6 years aged children with 70% with poor 
control.  
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DURATION OF DIABETES WITH HbA1C 
 
HbA1c gp 
Total 
Control Un control 
Duration of 
disease 
< 1 year 
Count 3 1 4 
% within Dur 
disease 75.0% 25.0% 100.0% 
1-3 yrs 
Count 17 29 46 
% within Dur 
disease 37.0% 63.0% 100.0% 
3-5 yrs 
Count 3 15 18 
% within Dur 
disease 16.7% 83.3% 100.0% 
>5 yrs 
Count 8 23 31 
% within Dur 
disease 25.8% 74.2% 100.0% 
Total 
Count 31 68 99 
% within Dur 
disease 31.3% 68.7% 100.0% 
 
P=0.091 
Table  23 shows no significant association between duration of diabetes 
and glycemic control 
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The chart 11 shows that the maximum glycemic control is in the 
patients belonging to the duration of diabetes less than 1 year. The 
majority of the children with poor control are more than 3 years among 
that 3 to 5 years have 83.3% and more than 5 years have 74.2%. 
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 REGIMEN OF INSULIN WITH  HbA1c   
 
HbA1c gp 
Total 
Control Un 
control 
Regimen 
insulin 
Twice 
Count 24 53 77 
% within 
Reg_insulin 
31.2% 68.8% 100.0% 
Thrice 
Count 7 15 22 
% within 
Reg_insulin 
31.8% 68.2% 100.0% 
Total 
Count 31 68 99 
% within 
Reg_insulin 
31.3% 68.7% 100.0% 
 
P=1.000 
Table  24 shows no significant association between regimen of insulin 
and glycemic control 
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Chart 12  The above chart explains that patients with either twice or 
thrice regimen both have the same percentage of glycemic control. 
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INSULIN DOSAGE GROUP   WITH  HbA1c GROUP 
 
 
HbA1c gp 
Total 
Control Un control 
Insulin gp 
0.5-0.99 
Count 8 14 22 
% within insulin gp 36.4% 63.6% 100.0% 
1.0-1.49 
Count 19 32 51 
% within insulin gp 37.3% 62.7% 100.0% 
1.5-2.0 
Count 4 19 23 
% within insulin gp 17.4% 82.6% 100.0% 
>2.0 
Count 0 3 3 
% within insulin gp 0% 100.0% 100.0% 
Total 
Count 31 68 99 
% within insulin gp 31.3% 68.7% 100.0% 
 
P=0.209 
 
Table  25 Shows no significant association between  insulin dosage  and 
glycemic control 
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The chart13 shows that the poor control children are having a higher  
insulin dose  
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SMBG  WITH  HbA1c 
 
HbA1c  gp 
Total 
Control Un control 
SMBG 
twice a week 
Count 28 56 84 
% within 
SMBG 
33.3% 66.7% 100.0% 
Less than  
twice a week 
Count 3 12 15 
% within 
SMBG 
20.0% 80.0% 100.0% 
Total 
Count 31 68 99 
% within 
SMBG 
31.3% 68.7% 100.0% 
 
P=0.378 
Table  26 shows no significant association between SMBG and glycemic 
control 
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Chart 14  The bar diagram shows that the children who do SMBG twice a 
week had a good control of about 33.3% and poor control of about 
66.7%.It also shows that the children who are doing SMBG less two 
times a week had a percentage of 20% and 80% for the  good control and 
poor control respectively. 
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COMPLIANCE WITH  HbA1c 
Compliance group with HbA1c group  
 
HbA1c gp 
Total 
Control Un control 
Compliance 
group 
Good 
Count 29 47 76 
% within 
complian_gp 38.2% 61.8% 100.0% 
Poor 
Count 7 16 23 
% within 
complian_gp 30.4% 69.6% 100.0% 
Total 
Count 36 63 99 
% within 
complian_gp 36.4% 63.6% 100.0% 
 
P=0.669 
 
Table 27 shows no significant association between compliance and 
glycemic control 
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The given chart  15 shows that the children with good compliance 
had a glycemic control of about 38.2% whereas children with poor 
compliance had a control of about 30.4 %, further both the groups had a 
poor glycemic control of about 61.8% and 69.6% respectively.  
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FOLLOW UP GROUP  WITH  HbA1c 
 
HbA1c_gp 
Total 
Control Un control 
Follow up 
group 
Regular(>=10 
visits) 
Count 15 29 44 
% within 
followup gp 34.1% 65.9% 100.0% 
Irregular(<10 
visits) 
Count 16 39 55 
% within 
followup gp 29.1% 70.9% 100.0% 
Total 
Count 31 68 99 
% within 
followup gp 31.3% 68.7% 100.0% 
 
P=0.753 
Table 28 shows no significant association between follow up and 
glycemic control 
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Chart 16 The bar diagram shows that the patients who came for regular 
visits had a control of 34.1% and 65.9% of good and poor control 
respectively. The patients on irregular visits had a good of about 29.1% 
and poor control of 70.9%.  
                    
  
89 
 
 HYPOGLYCEMIC EPISODES WITH  HbA1c GROUP 
 
Hypoglycemia 
Total 
Yes No 
HbA1c 
 
Control 
Count 23 8 31 
% within hypo 
group 74.1% 25.9% 100.0% 
 
Un control 
Count 34 34 68 
% within hypo 
group 50% 50% 100.0% 
Total 
Count 57 42 99 
% within hypo 
group 57% 42% 100.0% 
 
P=0.041 
Table 29  shows  significant association between hypoglycemic episode 
and glycemic control 
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The  chart  17 on hypoglycemic episodes explains that good control 
children had  an hypoglycemic episodes of 74.1% and 25.9%  did not 
have hypoglycemia. Further the poorly controlled children had a 50% 
chance of hypoglycemia. Overall there was a significant episodes of 
hypoglycemia of a p value of 0.041.   
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HOSPITALIZATION  WITH  HbA1c  
 
HbA1c  gp 
Total Control 
Uncontrolled 
control 
 
 
 
 
Hospitalization 
Yes 
Count 3 18 21 
% within 
Hospitalization 14.3% 85.7% 100.0% 
No 
Count 28 50 78 
% within 
Hospitalization 35.9% 64.1% 100.0% 
Total 
Count 31 68 99 
% within 
Hospitalization 31.3% 68.7% 100.0% 
 
P=0.103 
Table  30 shows no significant association between hospitalization and 
glycemic control 
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Chart 18 
In the given chart hospitalization incidence was seen in14.3%  in 
good controlled patients where as it was about 85.7% in the uncontrolled 
patients.  
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CHOLESTEROL  WITH  GLYCEMIC CONTROL 
 
 
HbA1c group 
Total 
Control Un 
control 
Chol 
group 
Normal 
Count 17 30 47 
% within chol 
group 77.3% 65.3% 69.1% 
Abnormal 
Count 5 16 21 
% within chol 
group 
   22.7% 34.7% 30.9% 
Total 
Count 22 46 68 
% within chol 
group 
100% 100% 100.0% 
 
P=0.468 
 
Table 31  shows no significant association between serum cholesterol and 
glycemic control 
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DISCUSSION 
The management of Type 1 DM in Children is a great challenge for 
health care workers, patients and their family members.  Current 
management standards target on optimizing glycemic control to reduce 
the risks of long term complications (40). 
Impact of Age on glycemic control: 
In the current study, the children in higher age group had maximum 
number with poor control i.e.75.5% whereas good control was present 
only in 24.5%.  Further these children had a mean HbA1c level of 9.5%. 
This finding is similar to the western studies. 
Urbach et al conducted a cross sectional study in 155 children and 
adolescents with type 1 dm in Portland. He observed that mean HbA1c 
level was 9.3% and  also observed that adolescents had a poor glycemic 
control with HbA1c level 0.56 higher than that of children aged  2 to 8 
years (41). 
It has been found that increasing age group was associated with 
poor glycemic control by  Vinelli M et al  (42). This may be attributed to 
increase in counter regulatory hormones and decrease in insulin 
sensitivity during the early stage of puberty.  Additionally, this age group 
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is vulnerable to psychological and social stressors which may result in 
poor control.   The poor glycemic control with increasing age in current 
study may be attributed to pubertal changes. 
The current study also shows that 70% of the children belonging to 
1 to 6 years of age had a poor glycemic control this may be attributed to 
the fact that these children are difficult to manage as they have a variable 
food intake and activity levels. In addition the early signs of 
hypoglycemia are difficult to recognize. 
Impact of duration of diabetes on glycemic control 
In the current study it is observed that children with duration of 
diabetes less than 1 year have 75.0% control while children with duration 
of diabetes more than 3 years have the least control of 16.7%. 
This is similar to the wisconsin Diabetes registry done by Gvan- 
Hua Hvang et al which shows that those with shorter duration of diabetes 
have better control.(43) 
This is an expected finding in newly diagnosed children of type1 
DM. This finding may be attributed to the  honey moon effect, in this 
period a relatively good glycemic control occurs due to residual β –cell 
effect. 
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Further in this study it is observed that increase in the duration of 
T1DM resulted in poorer control but it is not statistically significant as 
stated in other studies. 
Craig et al conducted cross sectional study in Australia in 1190 
children with T1DM and has observed that duration of diabetes a 
significant predictor of glycemic control. (17),(18).But the current study 
did not observe diabetes duration as a significant predictor. 
Impact of regimen of insulin on glycemic control  
The current study shows that glycemic control is similar in both 
twice daily and multiple dose regimens.  The DCCT has proven that 
intensive insulin regimen have demonstrated advantages over the more 
conventional insulin therapy(44).   The finding in the current study could 
be explained by the fact that only patients with poor glycemic control 
were started on thrice daily regimen as per our unit protocol whereas 
those with good control were maintained on twice daily regimen. 
Impact of SMBG on glycemic control 
In the current study the patients who had monitored their glucose 
levels twice a week had a higher rate of glycemic control (33.3%) 
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compared to the other group who monitored less frequently(20%), but 
this difference was not statistically different.  
The study conducted by Anderson et al found where more parental 
involvement in blood glucose measurement resulted in Lower HbA1C 
Levels.(45)  The lack of this association in the current study could be 
explained by the reasons for poor adherence to blood glucose 
measurement in our population and poor maintenance of records.   In the 
current study population it was not practical to download data from blood 
glucose meter as most patients did not carry meters to the clinic during 
visits. 
Impact of   compliance to therapy on glycemic control 
The current study on compliance has shown that children with 
good compliance had a glycemic control of 38.2% compared to the poor 
compliance group who has only 30.4 % glycemic control, though not 
statistically significant.  
Hood et al and peterson et all conducted a meta –analysis in 2492 
youth with type 1 DM  in  cincinnati, Ohio has found that and  as the 
adherence increase the HbA1C value decreases.(16) 
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Impact of follow up on glycemic control 
In the current study the glycemic control in children with regular 
follow up is 34.1% compared to the children with irregular follow up who 
has a percentage of 29.1, the difference not being statistically significant. 
A study conducted in portland by Urbach SL et al, La Franchiet al 
among 155 children of Type I DM revealed that children who attended 
the clinic irregularly had a poor HbA1C value(41). 
 
Impact of  glycemic control on hypoglycemic episodes 
In the current study, episodes of hypoglycemia occurred in about 
57.6%   and 42.4% of children did not have hypoglycemic episodes, 
which is comparable to other studies.  Craig et al conducted study 
regarding glycemic control and complication in children with Type I DM 
in Asia and western pacific region and observed the incidence of 
hypoglycemia is 73 per 100 patient per year (17).  Similar study 
conducted by Levine et al observed 62 per 100 person-years (46) 
On comparing the good control and poor control groups, 74.1% of 
the children in good control group had statistically significant 
hypoglycemic episodes while in the poorly controlled group only 50% 
had  hypoglycemia. Hypoglycemia is the limiting factor to tight glycemic 
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control in insulin-treated subjects since hypoglycemia can lead to 
cognitive dysfunction in children. DCCT in their studies have reported 
that lower glycated haemoglobin (HbA1c) level was a consistent risk 
factor for severe hypoglycaemia (7). However compromising glycemic 
control for hypoglycemia also has its own demerits of microvascular 
complications.  
Experts agree that at present, safest recommendation for improving 
Glycemic control generally in all children is to achieve the lowest HbA1c 
that can be sustained without causing  hypoglycemia while avoiding 
prolonged periods of significant hyperglycemia. 
 
Hospitalization 
In the current study, there were 21 children hospitalized for inter 
current illness.  This is comparable to the study conducted by Levine BS 
et al who observed the overall incidence rate of hospitalization was 13 per 
100 person-years(46).  This is more than 3 times the rate in general 
population. 
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Impact of lipid profile on glycemic control 
M. Loredana Marcovecchio et al made a longitudinal study in a 
population of  895 young subjects with type 1 diabetes with mean 
diabetes duration of 4.8 yrs and concluded that sustained, significant lipid 
abnormalities were related to age, BMI, duration and HbA1C (47). 
In the current study it was found that the elevated lipid profile 
especially sr.cholesterol  was seen in about 22.7% in good glycemic 
controlled patients compared to 34.7% in patients who have poor control.  
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STUDY HIGHLIGHTS 
The HbA1c values used in the study were not a single reading, but 
mean of all the values in the preceding year. Hence it reflected the child’s 
glycemic control over the one full year and was thus a reliable and stable 
parameter. 
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STUDY LIMITATIONS 
Including equal number of patients in different categories can bring 
out the effect of relation between that particular factor and glycemic 
control. 
This was not possible in the present study and that could have 
jeopardized the result, hence statistically significant results could not be 
obtained. 
 
 
 
 
 
  
103 
 
SUMMARY 
 A total of 99 children with Type I DM were included in this study. 
 The mean HbA1c was 9.2% comes under fair control group. 
 The glycemic control of 31.3% children came within the age 
appropriate glycemic control range. 
 The glycemic control of 68.7% children was above the age 
appropriate glycemic control range. 
 The following factors namely age, duration of diabetes, insulin 
dose, insulin regimen, SMBG, compliance to therapy, follow up, 
serum cholesterol and serum triglyceride did not have any impact 
on the glycemic control of type 1 diabetes in children. 
 Hypoglycemic episodes were found to be more common in 
children with good glycemic control which was statistically 
significant.  
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CONCLUSION 
The glycemic control in children with Type I DM attending the 
diabetic clinic at ICH & HC have a fair metabolic control. 
Hypoglycemic episodes were found to be more common in 
children with  good glycemic control which was statistically significant.  
From the current study, there is no evidence to suggest that 
demographic factors, diabetes related factors  and comorbid condition had 
impact on the glycemic control in children with type 1 diabetes. 
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 DATA COLLECTION FORM 
 
Participant ID no:              Address: 
P: Personal Characteristics 
1. Serial no 
2. Name: 
3. Age 1=(1to6) 
2=(6 to10) 
3=(10-12) 
Code  
4. sex 1=M 
2=F 
Code   
5 BMI 1. Above 3      Obese 
2. Between 2 to 3      
Overweight 
3. From 1 to 2        
possible risk of 
overweight 
4. From 1 to -2   Normal 
5. From   -2 to -3       
wasted 
6. Below -3        Severly 
wasted 
Code 
6 Primary care giver 1=father 
2=mother 
3=sibling 
4=guardian 
 
 
            
7. Educational profile of 
the caretaker 
1=illiterate  
2=primary school 
certificate 
3=middle school certificate 
4=High school completed  
5=intermediate or post 
school diploma 
6=Graduation or post-
graduation completed  
7=professional course 
completed 
Code 
 
 8 Family structure 1=both parents living 
together 
2=single parent 
3=no parent 
Code  
 
 
9 Family history of DM 1=yes 
a)1st degree 
b)2nd degree 
c)3rd degree 
2=no 
Code  
10 Mode of  DM onset 1=DKA 
2=Non DKA  
Code  
11 Duration of disease 1=<1yr 
2=1-3yrs 
3=3-5yrs 
4=>5yrs 
Code  
 
 
12 Regimen of Insulin 1=twice daily 
2=thrice daily 
Code  
13 Insulin dose (units/kg)  
 
 
14 Mode of insulin 
administration 
1=pen 
2=conventional 
 
15 SMBG 1=twice a week 
2=twice a month 
3=once a month 
4=> once a month 
Code  
16 Compliance to 
therapy 
1=good 
2=poor 
Code  
17 Follow up 1=regular 
2=irregular 
Code  
18  Hypoglycemic 
episodes 
1=yes 
2=no 
If yes whether 
1=symptomatic 
2=asymptomatic 
Code  
 
 
Code 
 19 Hospitalization for 
inter current illness 
1=yes 
2=no 
Code  
20 Episodes of DKA 1=yes 
2=no 
Code  
21 HbA1c   
22 Lipid profile   
23 Thyroid profile   
 
 
  
 
  
  
